To further explore ATR as a therapeutic target in NB, we tested the effect of BAY 1895344 on CLB-BAR (MYCN amplified, ALKΔexon4–11) and CLB-GE (MYCN amplified, ALKF1174V) NB cells (Fig. 1f, g). This evidence concerns the gene MYCN and neuroblastoma.